drugs

See the following -

It’s Time To Change American Disease-Management Into A Health-Fostering System

Joseph Mercola | Mercola.com | March 18, 2013

I’ve recently written a couple of articles about the exorbitant cost of medical care in the US, which is incompatible with the poor health outcomes of Americans at large. Americans pay the most for but reap the least amount of benefits from their health care, compared to other industrialized nations... Read More »

J&J Sets Drug Data Free In ‘YODA’ Collaboration With Yale

Drew Armstrong | Bloomberg | January 31, 2014

Johnson & Johnson (JNJ) will give academics access to data on clinical trials, a move that may prompt more companies to do the same. Read More »

Kenya Rolls Out Open-Source e-Health System

Steve Mbogo | The East African | September 15, 2012

An open source software e-health system being used in Kenya’s public hospitals since February has drastically cut costs and should pave the way for the model to be replicated in other East African countries. Read More »

Let’s Build A Drug! Biopharma Startup Launches Crowdsourcing Tool To Pick Compounds

Stephanie Baum | MedCity News | October 24, 2012

A biopharma startup believes that when it comes to deciding what conditions it should develop drugs to treat, the decision should be left to a public vote. Read More »

Let’s Fight Big Pharma’s Crusade To Turn Eccentricity Into Illness

Allen Frances | Wired | May 17, 2013

Nature takes the long view, mankind the short. Nature picks diversity; we pick standardization. We are homogenizing our crops and homogenizing our people. And Big Pharma seems intent on pursuing a parallel attempt to create its own brand of human monoculture. Read More »

Medicare Prescribes More Brand Name Drugs Than VA

Genevra Pittman | Reuters | June 10, 2013

Medicare Part D beneficiaries are two to three times more likely than those covered by the U.S. Department of Veterans Affairs to be prescribed brand name diabetes drugs rather than generics, a new study suggests. Read More »

Medicines That Kill: Separates Facts From Hype On The Dangers Of Medications

Press Release | Tyndale House Publishers | December 23, 2015

Medicines are a leading cause of death in North America, but we rarely hear about the deadly dangers both prescription and over-the-counter medications can cause. Cardiologist Dr. James L. Marcum wants to change all that with his new book Medicines That Kill: The Truth about the Hidden Epidemic (Tyndale House Publishers)...ln Medicines That Kill, Dr. Marcum shares stories of medications gone wrong and explains the dangers of using drugs without understanding how they might affect your body...

Read More »

Merchants Of Meth: How Big Pharma Keeps The Cooks In Business

Jonah Engle | Mother Jones | July 1, 2013

With big profits on the line, the drug industry is pulling out campaign-style dirty tricks to keep selling the meds that cooks turn into crank. Read More »

Merck 'Evergreens' Off-Patent Lipitor By Creating Combination Drug With No Additional Benefit

Glyn Moody | Techdirt | July 8, 2013

Big pharma often gets a rather rough ride here on Techdirt, what with its attempts to stop governments granting licenses for life-saving and low-cost generics in emerging countries, engaging in legal action to prevent drug safety information being released, and paying kickbacks to doctors. Read More »

Minimizing Legal Liability Or Upholding The Mission? - The Markingson Case Redux

Roy M. Poses | Health Care Renewal | March 15, 2013

There are new, and troubling developments in the long running case of Dan Markingson, the psychiatric patient and research subject who committed suicide while enrolled in a trial of anti-psychotic drugs at the University of Minnesota nearly 10 years ago. Read More »

Mining Electronic Health Records Reveals Clues Of Harmful Drug Reactions

Zina Moukheiber | Forbes | April 10, 2013

A study published today in Nature Clinical Pharmacology and Therapeutics showcases the potential power of sophisticated data analytics when applied to electronic health records on a large scale. Read More »

New Drugs Trail Many Old Ones In Effectiveness Against Disease

Sharon Begley | Reuters | June 3, 2013

Despite the more than $50 billion that U.S. pharmaceutical companies have spent every year since the mid-2000s to discover new medications, drugmakers have barely improved on old standbys developed decades ago. Read More »

New Wave Of Heroin Claims Hoffman And Others

Staff Writer | Washington Post | February 4, 2014

Heroin was supposed to be an obsolete evil, a blurry memory of a dangerous drug that dwelled in some dark recess of American culture.But smack never really disappeared. It comes in waves, and one such swell is cresting across the nation, sparking widespread worry among government officials and driving up overdose deaths — including, it appears, that of Oscar-winning actor Philip Seymour Hoffman. Read More »

NIH Launches Database Of Liver Injury-Linked Drugs

Anthony Brino | Government Health IT | October 15, 2012

The National Institutes of Health (NIH) has launched a database of pharmaceutical drugs associated with liver damage. Read More »

NIH Showcases Informatics Researchers As New Open Source Ventures Launch

Anthony Brino | Government Health IT | November 9, 2012

After the National Institutes of Health grew interested in bioinformatics, following breakthroughts in the 1990s, the National Centers for Biomedical Computing were created with the goal of advancing the field by a few leaps and bounds, because IT systems hadn’t quite caught up to molecular biology. Read More »